THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTA

NIH RePORTER · NIH · N01 · $484,000 · view on reporter.nih.gov ↗

Abstract

Advanced BioScience Laboratories, Inc. (ABL) is a global contract manufacturing organization with experience in biologics R&D, scale-up, and production following current Good Manufacturing Practices (cGMP). ABL partners with our clients to support GMP manufacturing needs. Dr. Wlodawer, Chief of the Macromolecular Crystallography Laboratory with the NCI-Frederick is working on a project, Chimeric ACE2 Peptide Ligand for Diagnostic Assays of SARS-CoV-2, under the Intramural Targeted Anti-Covid19 (ITAC) Program, which provides supplementary support for COVID-19 research activities for intramural investigators

Key facts

NIH application ID
10505894
Project number
75N91019D00024-P00003-759102000003-52
Recipient
LEIDOS BIOMEDICAL RESEARCH, INC.
Principal Investigator
LEONARD FREEDMAN
Activity code
N01
Funding institute
NIH
Fiscal year
2021
Award amount
$484,000
Award type
Project period
2020-08-31 → 2021-08-30